Inactive Instrument

Aceto Corporation

Aceto Corporation's Equity Buyback announced on December 11, 2009, has expired.

May 30, 2020

The company expired its plan on May 31, 2020.

Latest news about Aceto Corporation

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries	Mar. 25	CI
Actylis Launches A New Cgmp Wfi Generation, Storage, and Distribution System with Additional Iso Class 7 Manufacturing Space	23-09-21	CI
Actylis Opens a 30,000Ft² cGMP Facility to Bolster its Innovative Api Manufacturing Capabilities	23-02-27	CI
Aceto Corporation acquired Talus Mineral Company and Biotron Laboratories, Inc.	22-03-01	CI
Aceto Corporation acquired A & C Bio Buffer Limited.	21-10-11	CI
Aceto Corporation acquired Cascade Chemistry.	21-06-01	CI
Aceto Corporation acquired an unknown majority stake in Finar Ltd.	21-05-16	CI
Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering with Acquisition of A&C	21-04-15	CI
Aceto Corporation acquired A&C.	21-04-14	CI
Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing	21-03-15	CI
Aceto Corporation acquired IsleChem, LLC.	20-12-20	CI
Aceto Corporation's Equity Buyback announced on December 11, 2009, has expired.	20-05-30	CI
Aceto Corporation completed the acquisition of Syntor Fine Chemicals Limited.	20-04-16	CI
Aceto Corporation agreed to acquire Syntor Fine Chemicals Limited.	20-04-05	CI
Aceto Corporation Went Out of Business	19-10-01	CI
Second Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-09-20	CI
Second Modified Joint Liquidation Plan and Disclosure Statement Approved for Aceto Corporation	19-09-18	CI
Motion for Asset Sale Approved for Aceto Corporation	19-09-04	CI
Motion for Asset Sale Filed by Aceto Corporation	19-08-12	CI
Disclosure Statement Approved on Interim Basis for Aceto Corporation	19-07-26	CI
Aceto Announces Management Changes	19-06-20	CI
Aceto Corporation Announces Executive Changes	19-06-18	CI
First Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-06-18	CI
Joint Liquidation Plan and Disclosure Statement Filed by Aceto Corporation	19-06-17	CI
Aceto Corporation Announces the Termination of William C. Kennally, III as President and Chief Executive Officer of the Company	19-06-03	CI

Tri Harbor Holdings Corp., also known as Aceto, is a United States-based virtual manufacturer engaged in supplying specialty materials. The Company is primarily engaged in supplying its materials to life sciences and advanced technology end markets. The Company operates its business operations in nine countries, and distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+27.15%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.32%	359B
MERCK & CO., INC.	+16.52%	322B
ABBVIE INC.	+9.78%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.81%	149B

Other Pharmaceuticals